Experts of controlled clinical trials argue that conclusions about the eVects of medical interventions should be based on clinically relevant outcomes and not on the surrogates such as laboratory measurements. There are several examples in which the eVect on a clinically relevant outcome considerably diverged from the eVect on a surrogate end point (Fleming and DeMets 1996; Rothwell 2005) . In this respect, the recent paper by Davison and Gleeson (2006) is somewhat problematic.
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Davison and Gleeson motivated their study by noting that heavy exertion or long-duration exercise may increase the incidence of upper respiratory tract infection (URI) and by citing two trials in which vitamin C reduced the risk of URI associated with marathon runs. Evidence that vitamin C supplementation may be beneWcial for people who are under heavy physical stress is, however, substantially stronger than Davison and Gleeson present. A recent Cochrane meta-analysis focusing on vitamin C and the common cold found six placebo-controlled trials with participants under heavy acute physical stress (combined N = 642). In this group of trials, vitamin C reduced common cold risk by 50% (95% CI: ¡34 to ¡62%) (Douglas and Hemilä 2005; Hemilä 2006 ). Four of the trials, including those cited by Davison and Gleeson, were carried out with marathon runners, the Wfth with Canadian soldiers in a winter exercise (Sabiston and Radomski 1974) , and the sixth with schoolchildren in a skiing camp in the Swiss Alps (Ritzel 1961) . Moreover, heavy physical stress is a prominent feature of military recruits who concomitantly have elevated risk of pneumonia. Therefore the large (N = 674) randomized double-blind placebo-controlled trial with US Marine recruits is particularly interesting: vitamin C reduced the incidence of pneumonia by 85% (P[2¡t] = 0.044; Pitt and Costrini 1979; Hemilä 2004 Hemilä , 2006 .
In their trial, Davison and Gleeson compared vitamin C and control periods in the same participants exercising with a cycle ergometer and measured changes in the immune system. Such a study focusing on surrogates of infection susceptibility does not yield any information about whether vitamin C supplementation actually aVects the risk of URI or more severe respiratory infections-the clinically relevant outcomes-in physically stressed people.
On the other hand, the statistically very strong eVect of vitamin C on URI risk in physically stressed people (Douglas and Hemilä 2005) calls for immunological explanations. However, if the purpose of a study is to provide an immunological explanation for the vitamin C eVect on URI risk, the study should concurrently validate that vitamin C indeed has eVect on URI incidence at the particular experimental conditions, because the eVect has been found only in extreme physical stress. In ordinary people vitamin C has no eVect on URI risk (Douglas and Hemilä 2005) . The data for URI episodes were not collected by Davison and Gleeson and therefore we do not know whether vitamin C reduced URI incidence in their physical stress model. If the eVect of vitamin C on URI incidence is not conWrmed at the particular study conditions, we do not know whether the immunological Wndings have any relation to the biological mechanisms H. Hemilä (&) Department of Public Health, University of Helsinki, POB 41, Helsinki 00014, Finland e-mail: harri.hemila@helsinki.W explaining the eVect of vitamin C on URI risk, the clinically relevant outcome.
A further major problem of the Davison and Gleeson trial is the very small size (N = 9). In the Pitt and Costrini trial, the number-needed-to-treat (NNT) to prevent one case of pneumonia with vitamin C was 57. The NNT to prevent one case of the common cold with vitamin C was 7 in the Sabiston and Radomski trial, and 10 in the Ritzel trial. Concluding from such NNT values, it is evident that, as a minimum, several dozens of participants are needed at appropriate experimental conditions for a study to analyze whether immune system changes caused by vitamin C supplementation have any correlations with the clinical eVects.
